Skip to main content
. 2022 Jun 30;139(26):3752–3770. doi: 10.1182/blood.2021015108

Table 1.

Hazard rates for mRNA levels of RRM2 in AML patients treated with Ara-C

mRNA GSE14468 cohort TCGA cohort
Overall survival* Overall survival Overall survival* Overall survival
RRM2 0.68 (0.49-0.94; .02) 0.72 (0.51-1.01; .05) 0.70 (0.43-1.15; .16) 0.81 (0.49-1.33; .40)

Shown are hazard rates, 95% confidence intervals, and P values calculated with Wald test. Bold text indicates P < .05.

*

Data from univariate analysis.

Data adjusted for age and sex.